Latham & Watkins LLP represented the underwriters in the offering. Phreesia, Inc., a leading patient intake management platform, has announced the closing of the underwritten public […]
Phreesia’s $245.3 Million Common Stock Offering
Longboard Pharmaceuticals’ $80.0 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Longboard Pharmaceuticals, Inc. closed its initial public offering of 5 million shares of its common stock at […]
Cutera’s $138.25 Million Notes Offering
Goodwin Procter LLP advised the initial purchasers on the deal. Cutera, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Stifel, Nicolaus & Company, […]
Haymaker Acquisition Corp. III’s $300 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Haymaker Acquisition Corp. III, a blank check company, has announced the pricing of its initial public […]
Yellow Cake plc’s US$140 Million Equity Fundraising
Norton Rose Fulbright has advised Canaccord Genuity and Cantor Fitzgerald on the deal. Canaccord Genuity and Cantor Fitzgerald acted as joint bookrunners on a $140 million […]
I-Mab’s $177 Million ADSs Follow-on Secondary Offering
Davis Polk advised the representatives of the underwriters on the offering. Certain selling shareholders of I-Mab issued $177 million SEC-registered follow-on secondary offering of 3,283,950 American depositary […]
Nano-X Imaging’s Secondary Public Offering
Latham & Watkins LLP represented the underwriters in the offering. NANO-X IMAGING LTD (NASDAQ: NNOX), an innovative medical imaging technology company, has announced that it has […]
Critical Elements’ $15 Million Bought Deal Private Placement
Cassels acted for the underwriters. On February 11, 2021, Critical Elements Lithium Corporation closed a bought deal private placement of 13,636,400 units at a price of […]